GlassScriptPhysician profile
Edna Shifteh
NPI 1184720617
$6,984.54
in general payments reported to CMS, 2019-2025
37 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $125 · 2021: $1,622 · 2022: $3,425 · 2023: $760 · 2024: $711 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,812.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $849.70 | 2021-2023 | Reblozyl |
| Daiichi Sankyo INC. | $692.27 | 2021-2022 | |
| Janssen Biotech, INC. | $467.21 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $341.66 | 2021-2022 | |
| Cognoa, INC. | $303.56 | 2022 | |
| Genzyme Corporation | $268.77 | 2022 | |
| Exact Sciences Corporation | $226.09 | 2023 | Cologuard Collection Kit |
| Celgene Corporation | $215.65 | 2021 | |
| Gilead Sciences, INC. | $204.87 | 2022 | |
| Incyte Corporation | $185.99 | 2021-2022 | |
| Novocure INC. | $167.75 | 2023 | Optune |
| Madrigal Pharmaceuticals | $149.60 | 2025 | Rezdiffra |
| Ipsen Biopharmaceuticals, INC | $148.27 | 2022 | |
| Inspire Medical Systems, INC. | $145.08 | 2024 | Inspire |
| Janssen Scientific Affairs, LLC | $140.10 | 2023 | Tremfya |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $133.56 | 2021 | |
| Blueprint Medicines Corporation | $128.65 | 2021 | |
| Kite Pharma, INC. | $125.00 | 2022 | |
| Seagen INC. | $125.00 | 2022 | |
| Coherus Oncology, INC. | $125.00 | 2021 | |
| Glaxosmithkline, LLC. | $125.00 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $125.00 | 2020 | |
| Pharmacyclics LLC, An Abbvie Company | $125.00 | 2022 | |
| Amarin Pharma, INC. | $124.99 | 2024 | |
| Abbvie INC. | $124.96 | 2024 | |
| Astellas Pharma US INC | $124.86 | 2023 | Xtandi |
| Genentech USA, INC. | $121.83 | 2022 | |
| Alexion Pharmaceuticals, INC. | $121.83 | 2022 | |
| Epizyme, INC. | $120.26 | 2022 | |
| Puma Biotechnology, INC. | $116.03 | 2021 | |
| Evoke Pharma, INC. | $115.77 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $113.92 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $100.62 | 2024 | |
| Abiomed | $100.00 | 2024 | Impella |
| Tactile Systems Technology INC | $80.49 | 2022 | |
| Sanofi-Aventis U.S. LLC | $77.70 | 2025 | |
| Kyowa Kirin, INC. | $22.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edna Shifteh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.